Free AI-powered Mobile App for Skin Diseases Coming Soon
April 27, 2021 10:30 ET | Source: Skinopathy Skinopathy North York, Ontario, CANADA
TORONTO, April 27, 2021 (GLOBE NEWSWIRE) Skinopathy Inc., a Canadian medical technology company, will soon release a revolutionary skin disease mobile app that will change how we practice medicine.
Canadians who download the GetSkinHealth app and take pictures of their skin condition will get a pixel-by-pixel Artificial Intelligence (AI) analysis that will look for the presence of skin diseases. The AI will also offer the user the option to schedule an appointment with a skin specialist and hold virtual consultations right through the app.
Fifth indication for DUPIXENT
® in Canada following approvals for moderate-to-severe atopic dermatitis in adults and adolescents, severe chronic rhinosinusitis with nasal polyposis, and severe asthma in adults and adolescents.
For those living with atopic dermatitis, itch has the highest impact on a patient s quality of life.
1
Results from a survey conducted among Canadian children with atopic dermatitis found that 70 per cent experienced loss of sleep and 30 per cent experienced anxiety due to their condition.
2
MISSISSAUGA, ON, Feb. 23, 2021 /CNW/ - Sanofi Canada announced today that Health Canada has approved DUPIXENT
® (dupilumab injection) for the treatment of moderate-to-severe atopic dermatitis (AD) in children aged six to 11 years whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable.
Helping Hands: Building Soothing, Protecting, Repair and Care Products January 1, 2021 Contact Author Sarah FitzPatrick and Lorna Radford, Enkos Developments Ltd., Leatherhead, England
Close
Sponsored
Recently, hand care has experienced an unprecedented boom in consumer demand due to a heightened focus on sanitization and moisturization in response to the COVID-19 pandemic. Due to the pressurized market, regulations surrounding the manufacture and distribution of sanitizing products have been temporarily relaxed by governments
1, 2 across the world. Disruptions in supply have led to several non-cosmetic companies, and indeed consumers themselves,
3 trying their hand at sanitizer manufacturing.
Unfortunately, this amplifies risks to the consumer due to the heightened potential for dosage miscalculations or unwanted impurities (such as benzene and gasoline)